by John R. Fischer
, Senior Reporter | August 01, 2018
Computer-aided detection developer CureMetrix is teaming up with the University of Florida to produce the next generation of CAD tools for mammographers.
The California-based enterprise will provide the radiology department of the sunshine state university access to its physics-based AI and deep-learning software solutions as part of an educational and investigational endeavor that aims to evaluate its efficiency and impact in producing accurate readings of breast imagery.
"I believe that University of Florida is always looking to stay at the forefront of innovation. CureMetrix and more broadly Artificial Intelligence represent a paradigm shift in radiology," Kevin Harris, CEO of CureMetrix, told HCB News. "There is an opportunity, through use of AI-based tools, to improve clinical effectiveness and efficiency. Building products that help improve the sensitivity and specificity of doctors is good for the patient, the doctor, the hospital, and healthcare in general."
KA Imaging’s Reveal 35C detector, currently available as an upgrade solution in the US and selected geographies, can now be sold in the European Union. The detector recently obtained the CE Mark. Contact us at firstname.lastname@example.org to book a free demo.
Under the terms of the agreements, UF radiologists will evaluate the use of two of CureMetrix's investigational products, one being cmAssist. The physics-based CAD software is designed to identify and quantify regions of interest.
They will also be equipped with cmTriage, a worklist organizer and optimization tool for prioritizing studies based on regions of interest that are found to have suspicious findings. Clinical trials for both products are currently underway in preparation for their submission to the FDA in the coming months.
The agreement provides radiology residents with the opportunity to learn about the development of AI in medical imaging and its ability to advance access to and delivery of healthcare while enabling the university to maintain its quality of care and explore ways for improving clinical efficiency and patient outcomes.
In exchange, CureMetrix will utilize clinical data and anonymized images collected by the university over the last five years to further develop its CAD software for 3D tomosynthesis.
"By working closely with University of Florida, we will expand our firsthand knowledge of what doctors need to deliver better care," said Harris. "Combining that with access to their deep and rich data sets will help us continue to develop a CAD that works in all areas of radiology."
CureMetrix is pursuing similar collaborations for the advancement of its technology throughout the U.S. and around the world at this time. Back to HCB News